Production
- Controlled compounding
- Sterile manufacturing areas
- Filling processes
- Packaging and labelling
Manufacturing and Technology
Biogenix is developing Zimbabwe as the planned production base for its domestic launch and SADC strategy, with quality built into materials, facilities, processes, testing and documentation from the beginning.

Manufacturing Philosophy
Biogenix’s manufacturing approach is being designed around controlled processes, appropriate technology, traceability and continuous improvement rather than relying solely on final-product testing.
Facility design, equipment selection, documentation and quality systems are intended to work together as part of the proposed manufacturing model.
Planned IV-Fluid Platform
The planned large-volume parenteral IV-fluid operation is centred on 1-litre presentations. Blow-Fill-Seal is the proposed technology direction, subject to final equipment selection, qualification, validation and regulatory acceptance. Equipment is not presented as installed or commissioned.
Long-term target annual capacity
Subject to final equipment specifications, validated production rates, regulatory approval, market demand and operational performance.
This target is not current, installed, validated, available or guaranteed output.
Pharmaceutical inputs → Zimbabwe manufacturing platform → qualified distribution channels → healthcare institutions in approved markets.
This intended flow aims to shorten regional supply chains. Biogenix will initially remain dependent on imported active ingredients and selected pharmaceutical-grade inputs. Supply would begin only after manufacturing readiness and the necessary authorisations in each market.
Manufacturing Process
The sequence describes the intended high-level manufacturing model. Detailed processes and controls will depend on the product, selected technology and applicable requirements.
Planned controls begin with qualified inputs and pharmaceutical-water systems appropriate to the process.
Materials are intended to be measured and compounded through documented, controlled processes.
The proposed platform is intended to use an appropriate controlled forming and sterile filling approach.
Planned checks are intended to monitor process performance and product attributes during manufacture.
Packaging, documentation review and authorized batch-release controls are intended to precede supply.
Storage and distribution controls are intended to maintain traceability and appropriate product conditions.
Supporting Capabilities
These are planned capability areas and should not be interpreted as completed or operational facilities.
Generic Injectable Manufacturing
Each injectable medicine requires an individually appropriate manufacturing and control strategy. Depending on the product, processes may include aseptic processing, sterile filtration, filling and validated sterilization processes.
No single process is assumed to be suitable for every injectable product. Product and technology decisions will remain subject to development evidence and regulatory review.
Science, Technology and R&D
Biogenix aims to develop or access the scientific and technical capability required for responsible pharmaceutical development and technology transfer.
Quality and Partnerships
Explore the planned quality model or discuss technical, supply and development collaboration with Biogenix.